LYRA — Lyra Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.34m
- -$15.56m
- $0.40m
U.S. STOCKS ON THE MOVE-U.S. Steel, Freshpet, oil stocks
Lyra Therapeutics plunges as rhinosinusitis therapy fails in late-stage study
Brief: Point72 Asset Management, L.P. Reports 5.4% Passive Stake In Lyra Therapeutics As Of Nov 15- SEC Filing
Lyra Therapeutics Inc expected to post a loss of 32 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Frontdoor, gold miners, UniFirst
U.S. STOCKS ON THE MOVE-ARS Pharma, AMC, Eli Lilly
BTIG initiates Lyra coverage with 'buy'
Brief: Lyra Therapeutics Says Primary Endpoint Met With No Serious Adverse Events Observed
Lyra Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Lyra Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Lyra Therapeutics Inc Files For Shelf Of Up To 21.97 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP-Equitrans Midstream, Hasbro, Humana
U.S. STOCKS ON THE MOVE-Coherent, Copper miners, US banks
U.S. STOCKS ON THE MOVE-Ulta Beauty, Paramount Global, Microsoft
U.S. STOCKS ON THE MOVE-Marvell Technology, Tilray, Workday
Lyra Therapeutics rises on $50 mln private placement
Brief: Lyra Therapeutics Announces $50.0 mln Private Placement
Brief: Lyra Therapeutics Reports Q1 2023 Financial Results, Provides Corporate Update
Lyra Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview